Company research
SANUWAVE Health, Inc.
CIK 1417663Updated Nov 14, 2026
SecuritySNWV · NASDAQ · equity
Name history
RUB MUSIC ENTERPRISES, INC. · through Feb 1, 2010
SNWV price & chart
Loading TradingView…
NASDAQ:SNWV on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
SCHEDULE 13G/A - filed by Solas Capital Management, LLC regarding SANUWAVE Health, Inc.
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 35,599,000Source | 21,844,000Source | 36,605,000Source | 33,046,000Source | 21,013,000Source | 37,097,000Source | 30,855,000Source | 23,324,000Source | 37,343,000Source | 30,119,000Source | 22,416,000Source | 17,014,000Source |
| Property, Plant and Equipment, NetUSD | 1,994,000Source | 774,000Source | 2,255,000Source | 1,587,000Source | 947,000Source | 1,913,000Source | 449,000Source | 975,000Source | 1,972,000Source | 732,000Source | 938,000Source | 315,000Source |
| GoodwillUSD | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 3,202,000Source | 3,906,000Source | 2,887,000Source | 3,378,000Source | 4,082,000Source | 2,919,000Source | 3,554,000Source | 4,258,000Source | 3,026,000Source | 3,730,000Source | 4,434,000Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 9,602,000Source | 3,259,000Source | 9,376,000Source | 8,496,000Source | 2,460,000Source | 10,779,000Source | 8,501,000Source | 2,936,000Source | 11,959,000Source | 10,237,000Source | 1,797,000Source | 313,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 4,620,000Source | 2,836,000Source | 5,801,000Source | 3,848,000Source | 3,154,000Source | 6,000,000Source | 3,866,000Source | 3,008,000Source | 5,422,000Source | 3,329,000Source | 3,314,000Source | 1,730,000Source |
| Inventory, NetUSD | 6,814,000Source | 3,431,000Source | 7,070,000Source | 5,911,000Source | 2,731,000Source | 5,903,000Source | 5,457,000Source | 2,461,000Source | 5,934,000Source | 4,149,000Source | 2,951,000Source | 1,001,000Source |
| Assets, CurrentUSD | 22,633,000Source | 9,904,000Source | 23,201,000Source | 20,168,000Source | 8,724,000Source | 23,956,000Source | 18,831,000Source | 10,831,000Source | 24,627,000Source | 18,397,000Source | 9,784,000Source | 3,409,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,597,000Source | 378,000Source | 954,000Source | 1,913,000Source | 379,000Source | 1,274,000Source | 1,007,000Source | 2,426,000Source | 1,312,000Source | 682,000Source | 1,722,000Source | 365,000Source |
| Operating Lease, Right-of-Use AssetUSD | 431,000Source | — | 953,000Source | 653,000Source | — | 1,000,000Source | 400,000Source | — | 390,000Source | — | — | — |
| Other Assets, NoncurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 106,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 38,530,000Source | 82,107,000Source | 33,818,000Source | 47,821,000Source | 60,619,000Source | 35,259,000Source | 48,147,000Source | 70,919,000Source | 35,724,000Source | 42,836,000Source | 65,594,000Source | 55,081,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 9,000Source | 3,000Source | 9,000Source | 9,000Source | 1,182,000Source | 9,000Source | 9,000Source | 1,140,000Source | 9,000Source | 9,000Source | 1,140,000Source | 517,000Source |
| Additional Paid in CapitalUSD | 242,767,000Source | 178,397,000Source | 247,574,000Source | 241,248,000Source | 177,218,000Source | 245,943,000Source | 239,786,000Source | 175,842,000Source | 244,285,000Source | 238,685,000Source | 175,842,000Source | 150,533,000Source |
| Retained Earnings (Accumulated Deficit)USD | -245,717,000Source | -238,673,000Source | -244,806,000Source | -256,042,000Source | -218,016,000Source | -244,124,000Source | -257,097,000Source | -224,577,000Source | -242,685,000Source | -251,421,000Source | -220,049,000Source | -189,050,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 10,000Source | 10,000Source | 10,000Source | 10,000Source | 10,000Source | 10,000Source | 10,000Source | 0Source | 10,000Source | 10,000Source | -111,000Source | -67,000Source |
| Stockholders' Equity Attributable to ParentUSD | -2,931,000Source | -60,263,000Source | 2,787,000Source | -18,799,000Source | -39,606,000Source | 1,838,000Source | -20,812,000Source | -47,595,000Source | 1,619,000Source | -12,717,000Source | -43,178,000Source | -38,067,000Source |
| Liabilities and EquityUSD | 35,599,000Source | 21,844,000Source | 36,605,000Source | 33,046,000Source | 21,013,000Source | 37,097,000Source | 30,855,000Source | 23,324,000Source | 37,343,000Source | 30,119,000Source | 22,416,000Source | 17,014,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 19,577,000Source | 81,513,000Source | 18,173,000Source | 46,501,000Source | 59,965,000Source | 18,304,000Source | 47,268,000Source | 70,184,000Source | 17,847,000Source | 42,345,000Source | 64,755,000Source | 53,909,000Source |
| Operating Lease, Liability, CurrentUSD | 191,000Source | — | 5,000Source | 82,000Source | — | 300,000Source | 262,000Source | — | 157,000Source | — | — | — |
| Accounts Payable, CurrentUSD | 3,992,000Source | 4,137,000Source | 3,308,000Source | 4,002,000Source | 3,891,000Source | 3,320,000Source | 4,151,000Source | 5,062,000Source | 3,251,000Source | 3,728,000Source | 5,705,000Source | 6,760,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 28,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 3,586,000Source | 5,241,000Source | 8,605,000Source | 3,289,000Source | 4,794,000Source | 8,584,000Source | 3,581,000Source | 6,849,000Source | 8,382,000Source | 4,678,000Source | 5,999,000Source | 5,470,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Long-term Debt, Excluding Current Maturities | —Source | — | — | — | — | —Source | — | — | —Source | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 5,750,000Source | — | — | — | — | 5,750,000Source | — | — | 5,750,000Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 17,534,000Source | — | — | — | — | 14,762,000Source | — | — | 16,142,000Source | — | — | — |
| Other Liabilities, Noncurrent | — | — | — | —Source | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 294,000Source | 209,000Source | 974,000Source | 1,145,000Source | 1,028,000Source | 952,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,611,000Source | 975,000Source | 4,850,000Source | 1,514,000Source | — | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 617,000Source | 570,000Source | 2,296,000Source | 486,000Source | 53,000Source | 1,748,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 39,000Source | 1,308,000Source | 2,283,000Source | 1,198,000Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 54,000Source | 423,000Source | -521,000Source | -1,422,000Source | 1,546,000Source | -2,550,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 397,000Source | -1,517,000Source | 3,876,000Source | 2,455,000Source | -4,538,000Source | -17,169,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -158,000Source | -162,000Source | 3,433,000Source | -490,000Source | 21,000Source | 332,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 23,000Source | 162,000Source | 1,942,000Source | 490,000Source | — | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -1,419,000Source | -57,000Source | -5,587,000Source | 6,354,000Source | 5,211,000Source | 17,384,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,180,000Source | -1,736,000Source | 1,722,000Source | 8,440,000Source | 644,000Source | 534,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 9,602,000Source | 3,259,000Source | 9,376,000Source | 8,496,000Source | 10,779,000Source | 8,501,000Source | 11,959,000Source | 10,237,000Source | 1,797,000Source | 1,153,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 401,000Source | 1,118,000Source | 3,744,000Source | 4,311,000Source | 1,958,000Source | 3,712,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 27,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 121,000Source | -50,000Source | -13,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 1,397,000Source | — | 1,572,000Source | 1,132,000Source | 1,472,000Source | 975,000Source | 4,850,000Source | 1,514,000Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 57,000Source | 530,000Source | 1,461,000Source | 5,520,000Source | 6,911,000Source | 4,950,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 704,000Source | 704,000Source | 704,000Source | 704,000Source |
| DepreciationUSD | — | — | — | — | 137,000Source | 72,000Source | 118,000Source | 69,000Source | 392,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | — | — | -9,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 5,375,000Source | — | — | — |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | — | — | — | — | — | — | — | — | -210,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -477,000Source | 0Source | — | 0Source | — | 0Source | -477,000Source | 6,326,000Source | 0Source | -418,000Source |
| General and Administrative ExpenseUSD | — | — | 4,810,000Source | 2,545,000Source | 4,902,000Source | 4,368,000Source | 5,250,000Source | 4,843,000Source | 19,372,000Source | 11,348,000Source | 8,674,000Source | 12,556,000Source |
| GoodwillUSD | — | — | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source | 7,260,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | 0Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | 6,000Source | 0Source | — | — | 86,000Source | 27,000Source | 4,000Source | 2,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | 69,000Source | 0Source | 498,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 10,325,000Source | -20,657,000Source | -682,000Source | 551,000Source | -1,439,000Source | -6,118,000Source | 11,813,000Source | -31,372,000Source | -25,807,000Source | -10,293,000Source |
| Operating ExpensesUSD | — | — | 7,458,000Source | 5,114,000Source | 7,704,000Source | 6,410,000Source | 8,555,000Source | 6,774,000Source | 29,024,000Source | 19,133,000Source | 14,903,000Source | 21,363,000Source |
| Operating Lease, ExpenseUSD | — | — | 37,000Source | — | 64,000Source | 37,000Source | 46,000Source | 21,000Source | 123,000Source | — | — | — |
| Operating Lease, Lease IncomeUSD | — | — | 29,000Source | 69,000Source | — | 17,000Source | — | 51,000Source | — | 303,000Source | 1,143,000Source | 1,231,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 8,858,000Source | -22,610,000Source | -396,000Source | -887,000Source | -315,000Source | -6,719,000Source | 6,954,000Source | -36,762,000Source | -25,263,000Source | -1,339,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 10,300,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 19,000Source | 0Source | 556,000Source | — | — | — |
| Capitalized Computer Software, Amortization | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Gain (Loss) on Disposition of Assets | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 11,422,000Source | 9,291,000Source | 9,739,000Source | 10,147,000Source | 9,619,000Source | 9,291,000Source | 44,051,000Source | 32,331,000Source | 19,255,000Source | 15,511,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | 1,467,000Source | 1,953,000Source | -280,000Source | 1,438,000Source | -1,124,000Source | 601,000Source | 4,945,000Source | 5,417,000Source | -540,000Source | -8,952,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 8,858,000Source | -22,610,000Source | -396,000Source | -887,000Source | -315,000Source | -6,719,000Source | 6,954,000Source | -36,762,000Source | -25,263,000Source | -1,339,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | 11,899,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | 6,000Source | 0Source | — | — | 86,000Source | 27,000Source | 4,000Source | 2,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 10,325,000Source | -20,657,000Source | -682,000Source | 551,000Source | -1,439,000Source | -6,118,000Source | 11,813,000Source | -31,372,000Source | -25,807,000Source | -10,293,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 1.2Source | -6.49Source | -0.08Source | 0.06Source | -0.17Source | -0.72Source | 1.38Source | -7.03Source | -0.03Source | -0.02Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.46Source | -6.49Source | -0.08Source | -0.04Source | -0.17Source | -0.72Source | 0.41Source | -7.03Source | -0.03Source | -0.02Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 8,571,111Source | 3,185,495Source | 8,601,198Source | 8,561,737Source | 8,591,098Source | 8,547,675Source | 8,563,510Source | 4,462,883Source | 793,850,994Source | 549,470,787Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 9,140,668Source | 3,185,495Source | 8,601,198Source | 9,167,846Source | 8,591,098Source | 8,547,675Source | 9,082,510Source | 4,462,883Source | 793,850,994Source | 549,470,787Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 704,000Source | 704,000Source | 704,000Source | 704,000Source |
| Costs and ExpensesUSD | — | — | — | — | — | — | — | — | 590,000Source | 482,000Source | 484,000Source | 324,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 86,000Source | 27,000Source | 4,000Source | 2,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 222,000Source | 206,000Source | 251,000Source | 174,000Source | 246,000Source | 192,000Source | 880,000Source | 789,000Source | 752,000Source | 766,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | — | — | -9,000Source |
| General and Administrative ExpenseUSD | — | — | 4,810,000Source | 2,545,000Source | 4,902,000Source | 4,368,000Source | 5,250,000Source | 4,843,000Source | 19,372,000Source | 11,348,000Source | 8,674,000Source | 12,556,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 8,925,000Source | 7,067,000Source | 7,424,000Source | 7,848,000Source | 7,431,000Source | 7,375,000Source | 33,969,000Source | 24,550,000Source | 14,363,000Source | 12,411,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | — | — | -676,000Source | 551,000Source | — | — | 11,899,000Source | -31,345,000Source | -25,803,000Source | -10,291,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | — | -31,319,000Source | -25,783,000Source | -10,279,000Source |
| Interest Expense, DebtUSD | — | — | — | — | 518,000Source | 1,939,000Source | 546,000Source | 1,909,000Source | — | — | — | 12,771,000Source |
| Operating ExpensesUSD | — | — | 7,458,000Source | 5,114,000Source | 7,704,000Source | 6,410,000Source | 8,555,000Source | 6,774,000Source | 29,024,000Source | 19,133,000Source | 14,903,000Source | 21,363,000Source |
| Operating Lease, ExpenseUSD | — | — | 37,000Source | — | 64,000Source | 37,000Source | 46,000Source | 21,000Source | 123,000Source | — | — | — |
| Operating Lease, Lease IncomeUSD | — | — | 29,000Source | 69,000Source | — | 17,000Source | — | 51,000Source | — | 303,000Source | 1,143,000Source | 1,231,000Source |
| Research and Development ExpenseUSD | — | — | 345,000Source | 161,000Source | 628,000Source | 194,000Source | 660,000Source | 208,000Source | 1,353,000Source | 673,000Source | 579,000Source | 567,000Source |
| Selling and Marketing ExpenseUSD | — | — | 2,081,000Source | 2,202,000Source | 1,923,000Source | 1,674,000Source | 2,399,000Source | 1,531,000Source | 7,419,000Source | 6,323,000Source | 4,898,000Source | 7,474,000Source |
| Capitalized Computer Software, Amortization | — | — | — | — | — | — | —Source | — | — | — | — | — |
Filing attachments
ex99-1.htm · SCHEDULE 13G/A · 2026-07-31
Exhibit 99.1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of July 31, 2026, is by and among Opaleye Management Inc., Opaleye, L.P. and James Silverman (collectively, the “Filers”). Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D and/or 13G with respect to shares of Common Stock of SANUWAVE Health, Inc. beneficially owned by them from time to time. Pursuant to and in accordance with Rule 13d-1(k) …
Read attachment ↗ex99-1.htm · SCHEDULE 13G/A · 2026-05-04
Exhibit 99.1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of May 04, 2026, is by and among Opaleye Management Inc., Opaleye, L.P. and James Silverman (collectively, the “Filers”). Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D and/or 13G with respect to Common Shares of SANUWAVE Health, Inc. beneficially owned by them from time to time. Pursuant to and in accordance with Rule 13d-1(k) promulgate…
Read attachment ↗ex-991snwvpressreleasex416.htm · 8-K · 2026-04-16
EX-99.1 2 ex-991snwvpressreleasex416.htm EX-99.1 Document Exhibit 99.1 Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6 - $9.7 Million, Up 3-4% Year-over-Year Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended March 31, 2026, in line with prior guidance for Q1. EDEN PRAIRIE, MN, April 16, 2026 (GLOBE NEWSWIRE) Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-approved dire…
Read attachment ↗ex-991snwvpressreleasex408.htm · 8-K · 2025-04-08
EX-99.1 2 ex-991snwvpressreleasex408.htm EX-99.1 Document SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025) SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 revenue increased between 57% and 61% compared to Q1 2024. UltraMIST revenues for Q1 2025 increased by more than 65% versus…
Read attachment ↗